MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2018 International Congress

    Depression, apathy, fatigue in Parkinson with or without STN DBS

    L. Al-Nakeeb, M. Panisset (Montreal, QC, Canada)

    Objective: To determine the prevalence of depression, evaluate the relationship between depression, apathy and fatigue, and the impact of STN DBS on the same symptoms.…
  • 2018 International Congress

    Insular atrophy as a marker of depression in Multiple System Atrophy: A voxel-based morphometry study

    N. del Campo, N. Wolpe, O. Phillips, C. Arbus, F. Ory-Magne, M. Galitzky, C. Thalamas, C. Brefel-Courbon, A. Pavy-LeTraon, P. Péran, O. Rascol (Toulouse, France)

    Objective: The aim of this study was to determine the structural correlates of depressive symptoms in MSA patients. Background: Depression is highly prevalent among patients…
  • 2018 International Congress

    Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder

    Y. Liu, XY. Zhu, XJ. Zhang, Y. Feng, SH. Kuo, W. Ondo, YC. Wu (Shanghai, China)

    Objective: Study the relationship between RBD and other symptoms of PD. Background: Rapid eye movement sleep behavior disorder (RBD) and Parkinson’s disease (PD) are two…
  • 2018 International Congress

    Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease

    H.J. Yang, B.S. Park, J.Y. Park, E.M. Lee, S.Y. Kim, W.J. Kim, J.H. Kwon (Ulsan, Republic of Korea)

    Objective: We aim to assess the psychometric properties of the Korean version of Hospital Anxiety and Depression Scale (HADS) in a sample of early-stage Parkinson's…
  • 2018 International Congress

    The effects of bright light therapy on depression, sleep and circadian rhythm in patients with Parkinson’s disease and a depressive disorder: Results of a double-blind randomized controlled trial

    S. Rutten, C. Vriend, J. Smit, H. Berendse, E. van Someren, A. Hoogendoorn, J. Twisk, Y. vd Werf, O. vd Heuvel (Amsterdam, Netherlands)

    Objective: The aim of this study was to assess the efficacy of Bright Light Therapy (BLT) in reducing depressive symptoms in patients with Parkinson’s disease…
  • 2018 International Congress

    Clinical subtypes of Parkinson’s disease based on nonmotor symptoms: A cluster analysis

    X. Xu, P. Chan (Beijing, China)

    Objective: To classify patients with early Parkinson's disease based on nonmotor symptoms using a data-driven approach. Background: Heterogeneity of Parkinson’s disease provides the basis for…
  • 2018 International Congress

    Effect of mindfulness yoga on psychological distress in people with Parkinson’s disease (PD): A randomized controlled trial

    J.Y.Y. Kwok, J.C.Y. Kwan, M. Auyeung, C.T. Mok, C.K.Y. Lau, H.Y.L. Chan (New Territories, Hong Kong)

    Objective: To determine the effects of yoga versus conventional stretching and resistance training exercises (SRTE) on psychological, physical, spiritual, and health-related quality-of-life (HRQOL) outcomes among…
  • 2018 International Congress

    Quality of Life in Parkinson’s Disease: Impact of Depression and Apathy

    H. Nagayama (Tokyo, Japan)

    Objective: The aim of this study is to investigate whether depression and apathy are independently related to QoL in patients with PD. Therefore, we performed…
  • 2018 International Congress

    Is there a relationship between depression/anxiety and physical inactivity in Parkinson Disease?

    B. Aktar, B. Balci, B. Donmez Colakoglu (Izmir, Turkey)

    Objective: To investigate the relationships between depression/anxiety and activity limitations in Parkinson disease (PD). Background: Depression, anxiety are common non-motor symptoms in PD. Depression which…
  • 2018 International Congress

    Clinical differences between Parkinson’s disease motor phenotypes. Results from the COPPADIS Study Cohort

    I. Legarda Ramirez, B. Vives Pastor, M. Menéndez González, M. Blázquez Estrada, M. Seijo, M. Lage Castro, R. Vázquez Gómez, J. Ruíz Martínez, A. Bergareche Yarza, C. Valero, MM. Kurtis, JR. Pérez Sánchez, O. de Fábregues-Boixar, J. González Ardura, C. Prieto, C. Ordás Bandera, P. Mir, P. Martínez Martín, D. Santos García (Palma de Mallorca, Spain)

    Objective: To describe the prevalence of different motor phenotypes in a large cohort of Parkinson´s disease (PD) patients and to analyze their clinical features in…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley